These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36839614)

  • 1. Establishment of an Inactivation Method for Ebola Virus and SARS-CoV-2 Suitable for Downstream Sequencing of Low Cell Numbers.
    Olejnik J; Leon J; Michelson D; Chowdhary K; Galvan-Pena S; Benoist C; Mühlberger E; Hume AJ
    Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat Inactivation of Nipah Virus for Downstream Single-Cell RNA Sequencing Does Not Interfere with Sample Quality.
    Hume AJ; Olejnik J; White MR; Huang J; Turcinovic J; Heiden B; Bawa PS; Williams CJ; Gorham NG; Alekseyev YO; Connor JH; Kotton DN; Mühlberger E
    Pathogens; 2024 Jan; 13(1):. PubMed ID: 38251369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of scRNA-Seq Libraries Using Existing Inactivation Protocols.
    Sturdevant GL; Meade-White KD; Best SM; Speranza E
    Pathogens; 2024 Feb; 13(2):. PubMed ID: 38392905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planning Implications Related to Sterilization-Sensitive Science Investigations Associated with Mars Sample Return (MSR).
    Velbel MA; Cockell CS; Glavin DP; Marty B; Regberg AB; Smith AL; Tosca NJ; Wadhwa M; Kminek G; Meyer MA; Beaty DW; Carrier BL; Haltigin T; Hays LE; Agee CB; Busemann H; Cavalazzi B; Debaille V; Grady MM; Hauber E; Hutzler A; McCubbin FM; Pratt LM; Smith CL; Summons RE; Swindle TD; Tait KT; Udry A; Usui T; Westall F; Zorzano MP
    Astrobiology; 2022 Jun; 22(S1):S112-S164. PubMed ID: 34904892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 inactivation in laboratory animal tissues with 4% formaldehyde or 5% glutaraldehyde for transfer to biosafety level 1 laboratories.
    Pilchová V; Elmontaser Mergani A; Clever S; Ciurkiewicz M; Becker K; Gerhauser I; Baumgärtner W; Volz A; von Köckritz-Blickwede M; Schulz C
    Vet Pathol; 2024 Mar; 61(2):201-206. PubMed ID: 37698272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.
    Li D; Chen T; Hu Y; Zhou Y; Liu Q; Zhou D; Jin X; Huang Z
    J Virol; 2016 Oct; 90(19):8720-8. PubMed ID: 27440895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings.
    Widera M; Westhaus S; Rabenau HF; Hoehl S; Bojkova D; Cinatl J; Ciesek S
    Med Microbiol Immunol; 2021 Aug; 210(4):235-244. PubMed ID: 34196781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious viruses from transfected SARS-CoV-2 genomic RNA.
    Väisänen E; Jiang M; Laine L; Waris M; Julkunen I; Österlund P
    Front Bioeng Biotechnol; 2023; 11():1129111. PubMed ID: 37064222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of Material from SARS-CoV-2-Infected Primary Airway Epithelial Cell Cultures.
    Barrow KA; Rich LM; Vanderwall ER; Reeves SR; Rathe JA; White MP; Debley JS
    Methods Protoc; 2021 Jan; 4(1):. PubMed ID: 33430421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a non-denaturing detergent and a guanidinium-based inactivation agent on the viability of Ebola virus in mock clinical serum samples.
    Burton JE; Easterbrook L; Pitman J; Anderson D; Roddy S; Bailey D; Vipond R; Bruce CB; Roberts AD
    J Virol Methods; 2017 Dec; 250():34-40. PubMed ID: 28941617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a New Reverse Genetics System for Ebola Virus.
    Gan T; Zhou D; Huang Y; Xiao S; Ma Z; Hu X; Tong Y; Yan H; Zhong J
    mSphere; 2021 May; 6(3):. PubMed ID: 33952663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of inactivation procedures for SARS-CoV-2.
    Auerswald H; Yann S; Dul S; In S; Dussart P; Martin NJ; Karlsson EA; Garcia-Rivera JA
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of SARS-CoV-2 and COVID-19 Patient Samples for Contemporary Immunology and Metabolomics Studies.
    Eddins DJ; Bassit LC; Chandler JD; Haddad NS; Musall KL; Yang J; Kosters A; Dobosh BS; Hernández MR; Ramonell RP; Tirouvanziam RM; Lee FE; Zandi K; Schinazi RF; Ghosn EEB
    Immunohorizons; 2022 Feb; 6(2):144-155. PubMed ID: 35173021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Art of the Kill: Designing and Testing Viral Inactivation Procedures for Highly Pathogenic Negative Sense RNA Viruses.
    Olejnik J; Hume AJ; Ross SJ; Scoon WA; Seitz S; White MR; Slutzky B; Yun NE; Mühlberger E
    Pathogens; 2023 Jul; 12(7):. PubMed ID: 37513799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Inactivation of SARS-CoV-2 Using Gamma Radiation.
    Leung A; Tran K; Audet J; Lavineway S; Bastien N; Krishnan J
    Appl Biosaf; 2020 Sep; 25(3):157-160. PubMed ID: 36035758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient inactivation of Burkholderia pseudomallei or Francisella tularensis in infected cells for safe removal from biosafety level 3 containment laboratories.
    Emery FD; Stabenow JM; Miller MA
    Pathog Dis; 2014 Jul; 71(2):276-81. PubMed ID: 24449562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of RNA Viruses by Gamma Irradiation: A Study on Mitigating Factors.
    Hume AJ; Ames J; Rennick LJ; Duprex WP; Marzi A; Tonkiss J; Mühlberger E
    Viruses; 2016 Jul; 8(7):. PubMed ID: 27455307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training.
    Pilchová V; Prajeeth CK; Jendrny P; Twele F; Meller S; Pink I; Fathi A; Addo MM; Volk HA; Osterhaus A; von Köckritz-Blickwede M; Schulz C
    J Virol Methods; 2023 Jul; 317():114733. PubMed ID: 37068591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High degree of correlation between Ebola virus BSL-4 neutralization assays and pseudotyped VSV BSL-2 fluorescence reduction neutralization test.
    Konduru K; Shurtleff AC; Bavari S; Kaplan G
    J Virol Methods; 2018 Apr; 254():1-7. PubMed ID: 29355585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of noninfectious scRNAseq samples from SARS-CoV-2-infected epithelial cells.
    Osborn RM; Leach J; Zanche M; Ashton JM; Chu C; Thakar J; Dewhurst S; Rosenberger S; Pavelka M; Pryhuber GS; Mariani TJ; Anderson CS
    PLoS One; 2023; 18(2):e0281898. PubMed ID: 36827401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.